The SEDASYS System has been approved by the U.S. Food and Drug Administration for the delivery of the drug propofol to adults undergoing sedation for esophageal and colon cancer screenings.
The guidance document includes recommendations for practicing anesthesiologists and directors of anesthesia services at facilities that will incorporate the CAPS devices into their practices.
More Articles on Anesthesia:
12 Challenges for Anesthesia Groups Next Year
Anesthesia Group Acquisition Activity Grows in 2013
Presence United Samaritans Medical Center Honors Dr. Carmen Rocco
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
